News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
383,162 Results
Type
Article (26071)
Company Profile (60)
Press Release (357031)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (104567)
Career Advice (507)
Deals (16941)
Drug Delivery (51)
Drug Development (47668)
Employer Resources (47)
FDA (12278)
Job Trends (8464)
News (186428)
Policy (19447)
Tag
Academia (1752)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26893)
ALS (59)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (56)
Approvals (12341)
Artificial intelligence (174)
Autoimmune disease (11)
Automation (4)
Bankruptcy (142)
Best Places to Work (6914)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (40)
Bladder cancer (60)
Brain cancer (17)
Breast cancer (203)
Cancer (1465)
Cardiovascular disease (122)
Career advice (460)
Career pathing (13)
CAR-T (73)
Cell therapy (208)
Cervical cancer (14)
Clinical research (40624)
Collaboration (452)
Compensation (139)
Complete response letters (9)
COVID-19 (1497)
CRISPR (14)
C-suite (148)
Cystic fibrosis (43)
Data (1602)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (178)
Diagnostics (3547)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37193)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (52055)
Executive appointments (456)
FDA (13335)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (411)
Gene editing (40)
Generative AI (11)
Gene therapy (134)
GLP-1 (408)
Government (3042)
Grass and pollen (3)
Guidances (97)
Healthcare (12213)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (19)
Infectious disease (1569)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (67)
IPO (7068)
IRA (19)
Job creations (1842)
Job search strategy (397)
Kidney cancer (7)
Labor market (13)
Layoffs (173)
Leadership (4)
Legal (3640)
Liver cancer (57)
Lung cancer (234)
Lymphoma (101)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (57)
Medical device (12920)
Medtech (12923)
Mergers & acquisitions (10175)
Metabolic disorders (449)
Multiple sclerosis (56)
NASH (11)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1160)
NextGen: Class of 2025 (3935)
Non-profit (2831)
Now hiring (17)
Obesity (221)
Opinion (72)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (91)
Partnered (12)
Patents (117)
Patient recruitment (84)
Peanut (37)
People (34807)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11643)
Phase II (17589)
Phase III (14442)
Pipeline (773)
Policy (62)
Postmarket research (1670)
Preclinical (3637)
Press Release (18)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (162)
Rare diseases (186)
Real estate (2855)
Recruiting (16)
Regulatory (14247)
Reports (17)
Research institute (1613)
Resumes & cover letters (59)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (67)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2128)
Stomach cancer (8)
Supply chain (38)
Tariffs (14)
The Weekly (8)
Vaccines (363)
Venture capitalists (13)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (74)
Last 7 days (494)
Last 30 days (1607)
Last 365 days (18348)
2025 (6461)
2024 (19903)
2023 (22807)
2022 (30753)
2021 (33057)
2020 (32263)
2019 (28529)
2018 (21896)
2017 (18967)
2016 (18169)
2015 (21240)
2014 (16061)
2013 (13278)
2012 (14371)
2011 (14633)
2010 (13201)
Location
Africa (355)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (24594)
Australia (3903)
California (3182)
Canada (1254)
China (381)
Colorado (167)
Connecticut (176)
Delaware (123)
Europe (48335)
Florida (567)
Georgia (130)
Idaho (33)
Illinois (364)
India (14)
Indiana (230)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (647)
Massachusetts (2208)
Michigan (109)
Minnesota (278)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (36)
New Hampshire (60)
New Jersey (1163)
New Mexico (9)
New York (982)
North Carolina (564)
North Dakota (4)
Northern California (1405)
Ohio (134)
Oklahoma (3)
Oregon (23)
Pennsylvania (857)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (23)
Southern California (1218)
Tennessee (79)
Texas (561)
United States (13200)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (233)
West Virginia (3)
Wisconsin (43)
383,162 Results for "hansen medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Deals
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.
January 29, 2024
·
8 min read
Deals
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis will unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
December 13, 2023
·
13 min read
Business
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
LIfT BioSciences, a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.
December 21, 2023
·
4 min read
Bergen Prepares to Host International Conference on Hansen’s Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus
The Sasakawa Leprosy (Hansen’s Disease) Initiative and the University of Bergen are organizing a two-day conference in Bergen, Norway, on June 21-22, 2023, to commemorate the 150 th anniversary of the discovery of M. leprae , the causative agent of leprosy, in 1873.
June 19, 2023
·
4 min read
Press Releases
Promex Industries and QP Technologies Implement Sales/Marketing Reorganization, Promoting Rosie Medina to Promex Senior Vice President and Matt Hansen to QP Technologies Vice President
July 29, 2024
·
4 min read
Business
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of its United States subsidiary, Seegene Technologies.
March 17, 2022
·
2 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Deals
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - May 1, 2024
Oncternal Therapeutics, Inc. today announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior Director, Clinical Data Management.
May 1, 2024
·
3 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
1 of 38,317
Next
